Regeneron Pharmaceuticals
Price & Volume
Stats
See moreOpen | $555.82 |
Previous Close | $557.91 |
Day Range | $544.50-$560.50 |
52W Range | $525.99-$1,209.64 |
Market Cap | $60.9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $14.2B |
Revenue Growth (YoY) | 10.3% |
Gross Profit (12 Mos) | $7B |
Diluted EPS | $38.33 |
News
See moreYahoo Finance • 9 days ago
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Yahoo Finance • 20 days ago
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Yahoo Finance • 20 days ago
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,106 |
